has been cited by the following article(s):
[1]
|
Immune Checkpoint Inhibitors for Brain Metastases
Current Oncology Reports,
2017
DOI:10.1007/s11912-017-0596-3
|
|
|
[2]
|
Survival of patients with metastatic melanoma and brain metastases in the era of MAP-kinase inhibitors and immunologic checkpoint blockade antibodies: A systematic review
Cancer Treatment Reviews,
2016
DOI:10.1016/j.ctrv.2016.03.003
|
|
|
[3]
|
Gaining momentum: New options and opportunities for the treatment of advanced melanoma
Cancer Treatment Reviews,
2015
DOI:10.1016/j.ctrv.2015.05.012
|
|
|
[4]
|
Integrating first-line treatment options into clinical practice
Melanoma Research,
2015
DOI:10.1097/CMR.0000000000000200
|
|
|